Tamsulosin HCl

9 Drugs classified under this active ingredient

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
5-a Reductase Inhibitor/Alpha 1 Blocker. Dutasteride 0.5 mg, tamsulosin 0.4 mg.
CAPS: 30. 1 cap. dly. See lit.
Tmt. mod. to severe symp. BPH. Reduc. risk of acute urin. reten. (AUR) and surgery in pts. with mod. to severe sympt. of BPH.
C/I: Hyperses., women, child., adolesn., pts. with a hist. of orthost. hypotension, pts. with severe hepat. impair.

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
CAPS: 30. 1 cap orally 30 mins. aft. same
meal each day.
Tmt. mod.-severe sympts. BPH. Reduct.
risk acute urin. retent. (AUR), surg. in pts.
with mod.-severe sympts. BPH.

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
Hard caps.0.5mg + 0.4 mg
1 cap/day
Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.
C/I:  women, child. and adolesc. – hypersens. incl. to other 5-alpha reductase inhib., pts with sev. hepatic impairm.

α1 Blocker. Tamsulosin HCl 0.4 mg.
S.R. CAPS: 30. 1 cap dly aft. breakf. or
the 1st meal of the day.
Funct. sympts. BPH.

α1 Blocker. Tamsulosin HCl 0.4 mg.
PROLONG. RELEASE F.C. TABS: 30. 1 tab
dly independ. food. Swallow whole.
Lower urin. tract sympts. (LUTS) assoc.
with BPH.

α1 Blocker. Tamsulosin HCl 0.4 mg.
CAPS: 30. 1 cap. dly aft. breakf., taken
standing.
Funct. sympts. BPH.
C/I: Hypersens., orthostat. hypotens.,
severe hepat. insuffic.